Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06 April - 08 April 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- The study was conducted under GLP in accordance with the international guideline.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Storage condition of test material: At room temperature
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Mix
- Test concentrations with justification for top dose:
- Doses selected for the mutagenicity assay was based on data generated in preliminary study (Doses of 1.2, 4.9,20, 20, 78, 313, 1250 and 5000 μg per plate) where growth inhibition was observed at 313 μg per plate and more in all TA strains with and without metabolic activation at 1250 μg per plate in E. coli WP2 uvr A. Precipitation was also observed at 1250 μg per plate with and without metabolic activation. Therefore the doses for the main test were as follows;
0, 10, 20, 39, 78, 156 & 313 μg per plate for salmonella strains and 39, 78, 156, 313, 625 & 1250 μg per plate for WP2 uvrA. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: guideline recommended
Controls
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 2-acetylaminofluorene
- sodium azide
- benzo(a)pyrene
- other: 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide For TA100, TA98 & Wp2uvrA and 2-Methoxy-6-chloro-9-[3-(2-chloroethyl)aminopropylamino]acridine.2HCl for TA1537
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration (single, duplicate, triplicate): Triplicate
- Number of independent experiments: Three ; preliminary test and two main experiment
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): n/a
- Test substance added in medium; For tests without metabolic activation, 0.5 mL of 0.1 M Na-phosphate buffer (pH 7.4) and 0.1 mL of each fresh bacterial culture were added to each tube containing 0.1 mL of the test solution or or the negative control solution. For the test with metabolic activation, 0.5 mL of the S9 mix was added to each tube instead of 0.1 M Na-phosphate buffer. This was followed by pre-incubation at at 37°C for the 20 mins, then 2.0mL of top agar were added to the mixture, and the contents of each tube were pourers over the surface of the minimal glucose agar plate. And 0.1 mL of positive control solution was carried out equally.
For sterility test, 0.1 mL of test solution of the maximum concentration and 0.5 mL of S9 mix were added to each tube followed by 2.0 mL agar then transferred to surface of minimal glucose agar plate.
These preparation took place over UV absorbent filter.
As top agar, 0.5 mM biotin-0.5 mM L-histidine solution and 0.5 mM l-tryptophan solution were added to the safe agar solution (0.6% agar, 0.5% NaCl) by volume of 1/10 for TA and E.Coli strains respectively.
All plates wear incubated at at 37°C for 48 hrs, the number of revertant colonies were counted. Afterwards, growth inhibition of the test strains was checked using a stereoscopic microscope.
TREATMENT AND HARVEST SCHEDULE:
- Preincubation period, if applicable: 20 mins
- Exposure duration/duration of treatment: 48 hours at 37°C
- Harvest time after the end of treatment (sampling/recovery times): not stated - Rationale for test conditions:
- The study was based on the in vitro (pre-incubation) technique described by Ames et al (1975), Maron and Ames (1983), in which mutagenic effects are determined by exposing mutant strains of Salmonella typhimurium to various concentrations of the test item. These strains have a deleted excision repair mechanism which makes them more sensitive to various mutagens and they will not grow on media which does not contain histidine. When large numbers of these organisms are exposed to a mutagen, reverse mutation to the original histidine independent form takes place. These are readily detectable due to their ability to grow on a histidine deficient medium. Using these strains of Salmonella typhimurium revertants may be produced after exposure to a chemical mutagen, which have arisen as a result of a base-pair substitution in the genetic material (miscoding) or as a frameshift mutation in which genetic material is either added or deleted. Additionally, a mutant strain of Escherichia coli (WP2uvrA) which requires tryptophan and can be reverse mutated by base substitution to tryptophan independence is used to complement the Salmonella strains.
- Evaluation criteria:
- In the two main tests, if the number of revertant colonies on the test plates increased significantly in comparison with that on the control plates (based on twice as many as that of the negative control), and dose-response and reproducibility were also observed, the test substance was to be judged positive. The results of each concentrations were demonstrated with the mean and the standard deviation.
- Statistics:
- Not stated
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- MTEST-SPECIFIC CONFOUNDING FACTORS:
- Data on pH:Not specified
- Data on osmolality:Not specified
- Possibility of evaporation from medium:Not specified
- Water solubility:Not specified
- Precipitation and time of the determination: Precipitation was observed at 625 μg per plate with and without metabolic activation.
- Definition of acceptable cells for analysis: All bacterial strains must have demonstrated the required characteristics as determined by their respective strain checks according to Ames et al (1975), Maron and Ames (1983) and Mortelmans and Zeiger (2000).
- Other confounding effects: no
RANGE-FINDING/SCREENING STUDIES (if applicable): Was conducted,
growth inhibition was observed at ≥ 313 μg per plate in all TA strains with and without metabolic activation and at 1250 μg per plate in E. coli WP2 uvr A. Precipitation was observed in control groups at ≥ 1250 μg per plate with and without metabolic activation.
STUDY RESULTS - Concurrent vehicle negative and positive control data: Both with historical control range
For all test methods and criteria for data analysis and interpretation: - Concentration-response relationship where possible: No increase in revertant were observed.
- Statistical analysis; not stated
- Any other criteria: not stated
Ames test:
- Signs of toxicity: Toxicity were observed beginning at 650 μg per plate in all test conditions
- Individual plate counts: yes - Remarks on result:
- other: Not Mutagenic
Any other information on results incl. tables
Table 1. Preliminary Test Results
A term of test |
April 10 - 13th2018 |
|||||
With or without S9 mix |
Dose ug/plate |
No. Revertant colonies/plste |
||||
Base-pair substitution type |
Frame-shift type |
|||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||
-S9 |
0 |
106 |
14 |
28 |
31 |
8 |
1.2 |
106 |
15 |
24 |
30 |
7 |
|
4.9 |
118 |
16 |
21 |
18 |
9 |
|
20 |
112 |
16 |
24 |
21 |
11 |
|
78 |
130 |
12 |
22 |
26 |
8 |
|
313 |
104* |
8* |
29 |
25* |
7* |
|
1250+ |
108* |
15* |
25* |
24* |
8* |
|
5000+ |
118* |
13* |
25* |
19* |
4* |
|
+S9 |
0 |
123 |
13 |
29 |
36 |
16 |
1.2 |
126 |
8 |
29 |
35 |
16 |
|
4.9 |
112 |
11 |
36 |
35 |
13 |
|
20 |
117 |
13 |
27 |
27 |
17 |
|
78 |
98 |
14 |
24 |
38 |
18 |
|
313 |
136* |
10* |
28 |
24* |
14* |
|
1250+ |
102* |
12* |
27* |
23* |
15* |
|
5000+ |
109* |
6* |
20* |
24* |
10* |
|
Positive control -S9 |
Name |
AF-2 |
NaN3 |
AF-2 |
AF-2 |
ICR-191 |
Dosemg/plate |
0.01 |
0.5 |
0.01 |
0.1 |
1.0 |
|
No. Colonies/plate |
503 |
420 |
151 |
561 |
1375 |
|
Positive control +S9 |
Name |
B[a]P |
2AA |
2AA |
B[a]P |
B[a]P |
Dosemg/plate |
5.0 |
2.0 |
10.0 |
5.0 |
5.0 |
|
No. Colonies/plate |
682 |
218 |
325 |
212 |
59 |
Table 2. The 1st Main Test Results
A term of test |
April 17 - 20th2018 |
|||||
With or without S9 mix |
Dose ug/plate |
No. Revertant colonies/plste |
||||
Base-pair substitution type |
Frame-shift type |
|||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||
-S9 |
0 |
109±7.0 |
12±1.7 |
30±3.5 |
20±2.0 |
9±1.0 |
10 |
95±10.4 |
9±1.0 |
NT |
19±1.5 |
9±1.7 |
|
20 |
93±8.3 |
9±1.0 |
NT |
19±1.5 |
9±0.6 |
|
39 |
90±6.1 |
12±2.6 |
27±2.1 |
18±2.3 |
10±1.7 |
|
78 |
92±3.8 |
11±1.5 |
28±1.2 |
20±1.5 |
8±1.5 |
|
156 |
91±6.7* |
11±1.0* |
24±2.1 |
20±3.6* |
7±0.6* |
|
313 |
91±6.7* |
9±2.3* |
32±2.1 |
20±4.4* |
9±1.5* |
|
|
625+ |
NT |
NT |
23±3.5* |
NT |
NT |
|
1250+ |
NT |
NT |
23±4.6* |
NT |
NT |
+S9 |
0 |
106±5.3 |
13±2.1 |
32±2.6 |
27±2.5 |
16±2.6 |
10 |
110±3.2 |
13±3.0 |
NT |
30±15.0 |
14±1.0 |
|
20 |
100±2.1 |
10±2.1 |
NT |
25±3.1 |
15±2.3 |
|
39 |
95±3.2 |
10±2.1 |
31±2.9 |
26±3.2 |
16±2.3 |
|
78 |
101±3.6 |
12±1.5 |
32±1.5 |
30±3.5 |
16±2.6 |
|
156 |
93±4.0* |
11±3.2 |
37±2.5 |
30±4.2* |
14±1.7* |
|
313 |
88±6.6* |
8±1.7* |
25±3.1 |
24±5.2* |
13±0.6* |
|
625 |
NT |
NT |
31±2.6* |
NT |
NT |
|
1250+ |
NT |
NT |
30±3.2* |
NT |
NT |
|
Positive control -S9 |
Name |
AF-2 |
NaN3 |
AF-2 |
AF-2 |
ICR-191 |
Dosemg/plate |
0.01 |
0.5 |
0.01 |
0.1 |
1.0 |
|
No. Colonies/plate |
535±26.1 |
383±3.8 |
147±7.4 |
523±14.4 |
1305±92.9 |
|
Positive control +S9 |
Name |
B[a]P |
2AA |
2AA |
B[a]P |
B[a]P |
Dosemg/plate |
5.0 |
2.0 |
10.0 |
5.0 |
5.0 |
|
No. Colonies/plate |
728±26.6 |
286±15.5 |
345±34.4 |
175±9.3 |
63±70 |
Table 3. The 2nd Main Test Results
A term of test |
April 19 - 23th2018 |
|||||
With or without S9 mix |
Dose ug/plate |
No. Revertant colonies/plste |
||||
Base-pair substitution type |
Frame-shift type |
|||||
TA100 |
TA1535 |
WP2uvrA |
TA98 |
TA1537 |
||
+S9 |
0 |
117±11.0 |
13±1.7 |
29±4.2 |
27±1.0 |
18±3.2 |
10 |
131±8.1 |
9± 2.1 |
NT |
27±2.9 |
16±2.3 |
|
20 |
126±8.2 |
14±2.9 |
NT |
28±6.2 |
15±0.6 |
|
39 |
116±8.5 |
10±2.9 |
34±1.7 |
23±1.7 |
14±1.2 |
|
78 |
131±7.4 |
10±1.5 |
27±6.0 |
27±1.7 |
17±4.7 |
|
156 |
126±11.8* |
9±1.7 |
24±1.2 |
21±1.5* |
18±4.5* |
|
313 |
119±11.8* |
10±3.1* |
26±4.6 |
24±2.9* |
17±1.7* |
|
625+ |
NT |
NT |
29±4.0* |
NT |
NT |
|
1250+ |
NT |
NT |
25±3.5* |
NT |
NT |
|
-S9 |
0 |
113±12.3 |
12±1.0 |
29±4.2 |
27±1.0 |
18±3.2 |
10 |
113±13.3 |
10± 1.2 |
NT |
27±2.9 |
16±2.3 |
|
20 |
109±11.5 |
14±1.7 |
NT |
28±6.2 |
15±0.6 |
|
39 |
117±2.1 |
11±0.6 |
34±1.7 |
23±1.7 |
14±1.2 |
|
78 |
117±2.6 |
10±0.6 |
27±6.0 |
27±1.7 |
17±4.7 |
|
156 |
116±12.6* |
12±2.0* |
24±1.2 |
21±1.5* |
18±4.5* |
Please refer to 'Attached background material', where figures are presented in support of the lack of signficant increase in revertant colonies.
Applicant's summary and conclusion
- Conclusions:
- Based on the condition of the study, the test item did not induce mutagenicity in bacterial reverse mutation assay with or without metabolic activation.
- Executive summary:
OECD 471 ( 2018): The test item, was tested to evaluate its mutagenic potential using the preincubation method by measuring its ability to induce reverse mutations at selected loci of several strains of Salmonella typhimurium and at the tryptophan locus of Escherichia coli strain WP2 uvrA in the presence and absence of an exogenous metabolic activation system. Dimethyl sulfoxide (DMSO) was used as the vehicle.
Doses selected for the mutagenicity assay were 1.2, 4.9,20, 20, 78 1250 and 5000 μg per plate, based on data generated in preliminary study where growth inhibition was observed at ≥ 313 μg per plate in all TA strains with and without metabolic activation at 1250 μg per plate in E. coli WP2 uvr A. Precipitation was also observed at 1250 μg per plate with and without metabolic activation. All criteria for a valid study were met as described in the protocol.
The test item in DMSO, at concentrations of 2.018, 6.224 and 6.304 mg/mL, was stable at room temperature under the condition of the study. No contaminant colonies were observed on the sterility plates for the vehicle control, the test substance dilutions or the S9 and Sham mixes.
Precipitate was observed at 625 μg per plate and toxicity was observed beginning at 625 μg per plate with all conditions. No dose dependent increases were in all tester strain with or without metabolic activation. The test item was negative for mutagenicity in bacterial reverse mutation assay with or without metabolic activation.
Under the conditions of this study, test item did not meet the criteria for classification for mutagenicity in accordance with Globally Harmonized Classification System or the Regulation (EC) No. 1272/2008; relating to the Classification, Labelling and Packaging of Substances and Mixtures.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Embora a ECHA disponibilize muito material em linha na sua língua, uma parte desta página está disponível apenas em inglês. Mais informações sobreas práticas de multilinguismo da ECHA.
Bem-vindo ao sítio Web da ECHA O navegador Internet Explorer 7 (e versões anteriores) não é totalmente suportado por este sítio Web. Por favor atualize o seu Internet Explorer para uma versão mais recente.
Este sítio Web utiliza cookies a fim de garantir a melhor experiência possível nos nossos sítios Web.
Saiba mais sobre como utilizar cookies.